Clinical trial
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in…
NCT00002446 · Schering-Plough, Industry · Completed
Key facts
| NCT number | NCT00002446 |
|---|---|
| Title | Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients |
| Official title | Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients |
| Lead sponsor | Schering-Plough, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis, Oral, HIV Infections |
| Intervention type | Drug |
| Interventions | Posaconazole, Fluconazole |
| Enrollment | 300 |
| Start date | Aug 1, 1998 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | Barbados, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: